Nachman Norwood & Parrott’s Medtronic MDT Stock Holding History

Nachman Norwood & Parrott’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$902K	Buy	7,234 +45	+0.6%	+$5.65K	0.09%	139
2021 Q1	$850K	Buy	7,189 +452	+7%	+$53K	0.09%	137
2020 Q4	$789K	Buy	6,737 +85	+1%	+$9.36K	0.09%	136
2020 Q3	$691K	Sell	6,652 -92	-1%	-$9.24K	0.09%	131
2020 Q2	$619K	Buy	6,744 +447	+7%	+$42.9K	0.1%	135
2020 Q1	$568K	Buy	6,297 +870	+16%	+$92.6K	0.11%	126
2019 Q4	$616K	Buy	5,427 +27	+0.5%	+$2.96K	0.1%	145
2019 Q3	$587K	Buy	5,400 +99	+2%	+$10.3K	0.1%	143
2019 Q2	$516K	Buy	5,301 +1	+0%	+$91	0.09%	149
2019 Q1	$483K	Buy	5,300 +111	+2%	+$9.94K	0.09%	148
2018 Q4	$472K	Buy	+5,189	New	+$485K	0.1%	143

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nachman Norwood & Parrott's MDT Position: Q2 2021 in Review

Nachman Norwood & Parrott increased its Medtronic (MDT) stake by 0.63% in Q2 2021, buying an estimated $5.65K and bringing the position to 7,234 shares worth $902K. The position accounts for 0.09% of the portfolio, ranked #139.

Nachman Norwood & Parrott first reported a position in MDT in Q4 2018 and has held it in 11 quarters since. 2,004 funds tracked by Wall St. Rank hold MDT as of Q2 2021.

Nachman Norwood & Parrott held 7,234 shares of Medtronic worth $902K as of Q2 2021.
Nachman Norwood & Parrott bought 45 Medtronic shares in Q2 2021, an estimated $5.65K.
Medtronic made up 0.09% of Nachman Norwood & Parrott's portfolio in Q2 2021, its #139 holding.
Nachman Norwood & Parrott first reported a position in Medtronic in Q4 2018 and has held it in 11 quarters since.
2,004 funds tracked by Wall St. Rank held Medtronic as of Q2 2021.

Based on Nachman Norwood & Parrott's 13F filing for Q2 2021, filed 13 Aug 2021.